AstraZeneca Strikes a $1 Billion Deal to Acquire Biotech Innovator EsoBiotec

AstraZeneca plc has announced a definitive agreement to acquire EsoBiotec SA for up to $1 billion, aiming to advance innovative drug development and expand its biotech presence. Th...